SetPoint Medical
Ankit Shah has more than a decade of experience developing and commercializing innovative medical technology. He was a founding member of the commercialization team at Intersect ENT (NASDAQ: XENT) and held positions at Outset Medical, Medtronic, SV Health Investors, and the FDA.
This person is not in any offices
SetPoint Medical
SetPoint Medical is developing novel bioelectronic medicine therapies to treat those who suffer from autoimmune diseases such as rheumatoid arthritis, Crohn's Disease, and multiple sclerosis.